The annual Transcatheter Cardiovascular Therapeutics meeting is a key source of the latest clinical trial data on new stent technologies. Two key trials were presented, published in the Cardiology Journal, each using transcatheter patent foramen ovale (PFO) closure to prevent cryptogenic strokes.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now